Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABAA receptor changes
- 31 October 1999
- journal article
- Published by Elsevier BV in Journal of Chemical Neuroanatomy
- Vol. 17 (2), 75-97
- https://doi.org/10.1016/s0891-0618(99)00029-0
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Contrasting Effects of Raclopride and SCH 23390 on the Cellular Content of Preproenkephalin A mRNA in Rat Striatum: A Quantitative Non‐radioactive In Situ Hybridization StudyEuropean Journal of Neuroscience, 1992
- Entorhinal cortex lesion or intrahippocampal colchicine injection increases peripheral type benzodiazepine binding sites in rat hippocampusBrain Research, 1991
- Chronic quinolinic acid lesions in rats closely resemble Huntington's diseaseJournal of Neuroscience, 1991
- The quantification of brain lesions with anω3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegenerationBrain Research, 1990
- Abnormalities of Striatal Projection Neurons andN-Methyl-D-Aspartate Receptors in Presymptomatic Huntington's DiseaseThe New England Journal of Medicine, 1990
- Differential sparing of somatostatin‐neuropeptide y and cholinergic neurons following striatal excitotoxin lesionsSynapse, 1989
- Systemic approaches to modifying quinolinic acid striatal lesions in ratsJournal of Neuroscience, 1988
- Huntington's disease: Changes in tachykinin content in postmortem brainsAnnals of Neurology, 1987
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Somatostatin is increased in the basal ganglia in Huntington diseaseAnnals of Neurology, 1983